Treatment of influenza with neuraminidase inhibitors: virological implications

Clicks: 382
ID: 269400
2001
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 3 articles by views in Philosophical transactions of the Royal Society of London. Series B, Biological sciences

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Evaluation of the emergence of influenza virus resistance to neuraminidase inhibitors (NAIs) is now demanded following experience with amantadinamines. Preliminary data have indicated that NAI-resistant virus is unlikely to emerge readily in the clinic and this is consistent with the difficulty expe …
Reference Key
na2001philosophicaltreatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Roberts NA;;
Journal Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Year 2001
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/11779389
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review animals humans pubmed abstract nih national institutes of health national library of medicine drug resistance multiple enzyme inhibitors / pharmacology enzyme inhibitors / therapeutic use* antiviral agents / therapeutic use* viral* influenza human / drug therapy* antiviral agents / pharmacology influenza a virus / isolation & purification influenza a virus / drug effects human / virology* guanidines influenza b virus / drug effects oseltamivir pyrans zanamivir pmid:11779389 pmc1088566 doi:10.1098/rstb.2001.1002 n a roberts acetamides / pharmacology acetamides / therapeutic use influenza a virus / genetics* influenza b virus / genetics influenza b virus / isolation & purification neuraminidase / antagonists & inhibitors sialic acids / pharmacology sialic acids / therapeutic use

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.